
General Mills Lowers Sales Projections Amid Declining Snacking Trends
In a surprising turn of events, General Mills has adjusted its sales guidance downward, attributing this decision to an observable slowdown in its snacking segment. The food conglomerate, well-known for its broad range of snack products, reported in a recent earnings call that consumer spending patterns are shifting, leading to slower growth in one of its key categories.
Continue reading
Novartis Ups Sales Forecast Driven by Strong Demand for Cancer and Inflammatory Drugs
In a significant enhancement to its financial outlook, Novartis has raised its sales guidance, attributing this upward revision to robust demand for its cancer and inflammatory condition treatments. The global healthcare company announced that it expects an increase in sales growth for 2024, increasing from its previous estimates amid promising results from its advanced therapeutic offerings.
Continue reading